M&A Deal Summary |
|
---|---|
Date | 2019-01-22 |
Target | Prisma Medios de Pago |
Sector | Information Technology |
Buyer(s) | Advent International |
Deal Type | Buyout (LBO, MBO, MBI) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Private Equity Firm |
---|---|
Founded | 1984 |
PE ASSETS | 76.0B USD |
Size | Mega |
Type | Sector Agnostic |
Advent is a global private equity firm that targets investments in North America, Europe, Asia, and Latin America. Advent's emerging market efforts are concentrated in Central Europe and Latin America. Advent seeks transactions valued between $50 million and $5 billion and can commit up to $2 billion of equity capital per investment. Broad areas of interest include business & financial services, retail & consumer, technology, media, & telecoms, healthcare & life sciences, and industrial. Prospective transaction types include buyouts, growth capital financings, take privates, and recapitalizations. Advent was formed in 1984 and is based in Boston, Massachusetts.
DEAL STATS | # |
---|---|
Overall | 267 of 339 |
Sector (Information Technology) | 17 of 32 |
Type (Buyout (LBO, MBO, MBI)) | 139 of 150 |
Country (Argentina) | 6 of 6 |
Year (2019) | 2 of 16 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2019-01-07 |
Concardis
Eschborn, Germany Concardis is a payment service provider that offers intelligent solutions to meet the extensive requirements for a modern cashless payment process the ability to accept payments made with all major credit and debit cards, including card terminals and contactless payment processes for face-to-face retailers, innovative solutions for e-commerce and m-commerce, as well as support in the form of customer management. Concardis was founded in 2003 and is based in Eschborn, Germany. |
Sell | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2019-01-28 |
BioDuro-Sundia
Irvine, California, United States BioDuro-Sundia is a global life science contract research and development organization that provides biopharmaceutical clients and partners with comprehensive, fully integrated drug discovery services spanning target identification to IND filing, through to GMP manufacture of drug substance for clinical trials. BioDuro-Sundia was founded in 1996 and is based in Irvine, California. |
Buy | - |